EBS icon

Emergent Biosolutions
EBS

Overview Fund Activity

126 hedge funds and large institutions have $451M invested in Emergent Biosolutions in 2013 Q3 according to their latest regulatory filings, with 19 funds opening new positions, 62 increasing their positions, 29 reducing their positions, and 5 closing their positions.

Holders
126
Holders Change
+13
Holders Change %
+11.5%
% of All Funds
4.09%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.06%
New
19
Increased
62
Reduced
29
Closed
5
Calls
$36K
Puts
–
Net Calls
+$36K
Net Calls Change
+$35K

Top Buyers

1
SCA
1
SAC Capital Advisors
Connecticut
$16.3M
2
BFA
2
BlackRock Fund Advisors
California
$28.4M
3
Goldman Sachs
3
Goldman Sachs
New York
$5.56M
4
NI
4
Numeric Investors
Massachusetts
$2.62M
5
CRC
5
Curi RMB Capital
Illinois
$1.77M

Top Sellers

1
Millennium Management
1
Millennium Management
New York
$2.62M
2
Renaissance Technologies
2
Renaissance Technologies
New York
$11.4M
3
BNP Paribas Asset Management
3
BNP Paribas Asset Management
France
$0
4
Bank of New York Mellon
4
Bank of New York Mellon
New York
$63.2M
5
State Street
5
State Street
Massachusetts
$16.8M
Name Holding Trade Value Shares
Change 		Shares
Change %
BNP Paribas Asset Management
126
BNP Paribas Asset Management
France
– -$2.36M -163,497 Closed
FNYS
127
First New York Securities
New York
– -$797K -55,300 Closed
RA
128
Royce & Associates
New York
– -$438K -30,386 Closed
Tudor Investment Corp
129
Tudor Investment Corp
Connecticut
– -$316K -21,900 Closed
TRCT
130
Tower Research Capital (TRC)
New York
– -$4K -300 Closed
2 3 4 5
6